Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1242.00
-3.50 (-0.28%)
< Home < Back

Dr. Reddy's launches generic version of Vimovo tablets in US market

Date: 28-02-2020

Dr. Reddy’s Laboratories has launched the first generic version of Vimovo tablets, used to treat rheumatoid arthritis, in the US market. The company announced the first-to-market launch of Naproxen and Esomeprazole Magnesium delayed-release tablets in the US market.

The company's product is the generic version of Vimovo tablets approved by the US Food and Drug Administration (USFDA).

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.